FYTEXIA invites you to their event

Partner roundtable - Benegut® new clinical study

About this event

Dear partners,

You are invited to join this 30-minute training to discover the results of the new clinical study conducted with Benegut® targeting digestive comfort.

Benegut® is a patented botanical extract from shiso leaves (Perilla frutescens) combining antispasmodic effect and action on tight junction leakage. Benegut® is clinically proven to contribute to a significant reduction of intestinal discomfort and is now demonstrated to act right after the first intake of 300 mg.

During this roundtable session, we would like to take the opportunity to bring together our valuable partners to discuss communication opportunities around Benegut®.

This 30-minute virtual roundtable will cover:

  • The new sales presentation for Benegut®
  • A focus on the last clinical data from the acute study
  • The latest product developments with Benegut®
  • An overview of the tools available to promote Benegut®
  • A discussion with your peers in different territories

Do not hesitate to invite your team to join this session of partner roundtable by Fytexia.

Hosted by

  • Team member
    T
    Laure Nogier Marketing Operations Manager @ FYTEXIA

    Dietitian with an MSc degree in food sciences and nutrition, Laure Nogier manages Marketing & Communication projects at Fytexia to provide our customers with valuable contents, market insights and turnkey solutions for successful products.

  • Team member
    T
    Sophie Loisel Business Unit Director, Botanicals @ FYTEXIA

    Dietitian with an MSc degree in food sciences, Sophie Loisel joined Fytexia in 2011 after starting her career promoting natural ingredients in the US market. Sophie has a 15 years experience in business development, communication, and partnerships around dietary supplements.

FYTEXIA

Life sciences, active nutrients & scientific support.

Fytexia is an expert life science company developing scientifically-supported active nutrients for dietary supplements.